CEO Fozia’s role within Magnitude is to lead and deliver the strategy and vision for growth of the business. Fozia is passionate about delivering profitable innovations by effectively leading multifunctional teams. Along with the experts at Magnitude, she is committed to delivering a bespoke service to our clients tailored to answering their specific research questions. Fozia joined us with over 14 years senior leadership experience across the medical device, pharmaceutical and nicotine industries. She has extensive experience of working in the global life sciences sector in R&D, CRO and GTM environments. Fozia has a PhD in molecular physiology from the University of Edinburgh and started her career in industry at GlaxoSmithKline. She subsequently worked for British American Tobacco and Nicoventures Holdings, where she had a wide range of responsibilities, including product development, project delivery, and revenue growth. She also held senior leadership roles at Broughton Life Sciences, where she led […]

CSO David’s role within Magnitude is as our lead consultant to diagnose customer challenges, determine where our expertise and services can best progress customer research aims, and ensure projects deliver. David is well respected in the academic fields of C. elegans and ageing biology. As a postdoc, he worked with David Gems, Ronald Plasterk and Erik Jorgensen. He is now Professor at the Department of Biosciences, Durham University and Chair of the British Society for Research on Ageing. David has over 3000 citations of his work. David is passionate about applying the strength of C. elegans research to industrial application and he cofounded the Magnitude Biosciences team to bring reliable automated technology together with experienced C. elegans scientists to bring increases in productivity to the whole field. Back to Team

CTO With a deep mathematical understanding, Chris is the genius behind the software at the heart of the WormGazer™. Chris is an instrumentation specialist and is constantly thinking about how we can solve customers’ problems in the lab. Chris’ daily challenges include finding new ways to adapt our hardware and software for continuous improvement to improve reproducibility of experiments and the quality of the science that we deliver. Chris’ extensive experience of finding solutions for biological labs enables him to create the technology to quantify your research question. Back to Team

Non-Executive Director & Chair of the Board Sally has operational, strategic and board level experience gained over more than 30 years as a senior executive in multiple early stage biopharmaceutical companies and service providers. She has developed and led drug development programmes for a wide range of product types and indications and interacted with regulatory agencies in Europe and the US. Sally has been involved in developing and implementing strategies for growth which have included building sales and the team in a contract research organisation and identification and participation in multiple M&A transactions and two IPOs Back to Team

Head of Operations Sara oversees the operational needs of the business and joined Magnitude with over a decade of continuous improvement, quality, production and health and safety experience. Sara has a BSc in Biology and has worked in a variety of industries including medical devices, FMCG and animal feed where she had been responsible for a number of sites. Sara’s commitment to operational excellence alongside her ‘anything is possible’ attitude and scientific background makes her a perfect fit to help support our CEO with the development and implementation of our business objectives and company vision. Back to Team

Senior Research Scientist Karthik is a skilled professional with a Ph.D. in Biochemistry, specializing in the investigating Mitochondrial Biogenesis. His research journey encompasses working with diverse systems like C. elegans, yeast, and human cells, where he made significant contributions by discovering a novel mitochondrial disease pathogenesis mechanism. In his postdoctoral research work at the University of Bern, Switzerland, he led a research project to create a C. elegans-based leukemic disease model and develop high-throughput assays for drug discovery studies. His proficiency extends to the creation of numerous transgenic worms, showcasing a strong foundation in C. elegans genetics, cell, and molecular biology techniques. With over a decade of international exposure, Karthik brings the experience of working with scientists from diverse specializations and various locations around the world, which contributes to strong communication, collaboration, and problem-solving skills. His scientific accomplishments include many research articles and co-inventorship of a patent application focused on […]

Commercial Innovation Manager Frederique has a PhD in Cell Biology and many years experience working in the life sciences CRO environment. She brings substantial Business Development skills to Magnitude Biosciences and has extensive experience working with life science, health products and manufacturing companies of all different sizes across a wide range of research areas, helping to understand and address different research problems. Her scientific background, breadth and depth of biological sciences knowledge, and rich commercial experience enable her to understand customer challenges and help to find the right solution to address them. She is proactive and well-organised, extremely responsive and a great communicator, always ensuring of our customer projects get off to the right start. Back to Team

Research Scientist Jason holds an MSc in Molecular Medicine, which he achieved at the University of Reading. His degree explored a variety of areas such as synthetic biology, cancer biology, and regenerative medicine. For his thesis, his MSc research focused on using C. elegans to investigate the effects of microplastic exposure on Parkinson’s-like symptoms including motor deficits and alpha-synuclein accumulation. His work explored how environmental factors influence neurodegenerative disease progression, by utilising molecular techniques, fluorescence microscopy and developing behavioural assays. Jason’s time at the University of Reading reinforced a strong interest in neurodegeneration and ageing, with a particular interest in how insights from model organisms can be translated to advance therapeutic research. At Magnitude, Jason brings his scientific knowledge with an organised attitude and attention to detail. Back to Team

Research Scientist Feng brings over a decade of experience working with C. elegans to model human disease, with expertise in high-throughput screening, molecular biology, microbiology, NGS, and bioinformatics. He has contributed to research spanning neurodegeneration, ageing, microbiome interactions, genetic variation, and cancer signalling. His PhD in Systems Biology at the University of Manchester involved using high-throughput liquid screening methods to probe the effects of natural genetic variation on cancer signalling and population fitness, alongside developing pipelines for data processing and statistical analyses. As a postdoctoral researcher at the University of Edinburgh, he identified novel protective genes against dopaminergic neurodegeneration through EMS mutagenesis screens with high-throughput worm sorting and mapping causal neuroprotective mutations using custom pipelines and tools he helped develop for bulked segregant WGS approaches. Shifting fields, he explored the benefits of commercially available probiotics on α-synuclein aggregation in a Parkinson’s disease model. Successes led to a PDUK-funded project on exploring the […]

Commercial Research Scientist Mireya has worked with a number of model organisms over her scientific career, including chickens, zebrafish, and finally C. elegans. Mireya obtained her doctorate in Cell Biology from the University of Kent investigating the relationship between ageing C. elegans and their natural microbiome. Throughout her PhD, she evaluated the impact of a defined bacterial community on healthspan in wildtype nematodes as well as in nematode models of human disease. Following on from this, her postdoctoral work focused on identifying biomarkers and interventions to prevent motor decline in ageing worms. Mireya is just as enthusiastic about research outside of the lab, with a real passion for science communication. At Magnitude, Mireya is able to merge her equal excitement for biology and for people, offering bespoke solutions to suit client needs. Back to Team